Biblio

21 resultats trouvés
Filtres: Mot-clé is Inflammatory bowel disease  [Clear All Filters]
A
Certain M-C., Georges M., Beltramo G., Schenesse D., Mouillot P., Tankere P., Bonniaud P..  2020.  Adalimum ab-induced interstitial pneumonia in patients with inflammatory bowel disease. RESPIRATORY MEDICINE AND RESEARCH. 78:100790.
Ries M, Moulari B, Boushehri MAShetab, Ali MEhab, Molnar D, Beduneau A, Pellequer Y, Lamprecht A.  2022.  Adalimumab Decorated Nanoparticles Enhance Antibody Stability and Therapeutic Outcome in Epithelial Colitis Targeting. PHARMACEUTICS. 14:352.
Jhundoo HD, Siefen T, Liang A, Schmidt C, Lokhnauth J, Moulari B, Beduneau A, Pellequer Y, Larsen CCasper, Lamprecht A.  2021.  Anti-inflammatory effects of acacia and guar gum in 5-amino salicylic acid formulations in experimental colitis. INTERNATIONAL JOURNAL OF PHARMACEUTICS-X. 3:100080.
Wendling D, Sondag M, Verhoeven F, Vuitton L, Koch S, Prati C.  2018.  Arthrits occurrence or reactivation under Vedolizumab treatment for inflammatory bowel disease. A four cases report. JOINT BONE SPINE. 85:255-256.
C
Costa RFA, Ferrari MLA, Bringer M-A, Darfeuille-Michaud A, Martins FS, Barnich N.  2020.  Characterization of mucosa-associatedEscherichia colistrains isolated from Crohn's disease patients in Brazil. BMC MICROBIOLOGY. 20:178.
D
Pouillon L, Lamoureux A, de Chambrun GPineton, Vuitton L, Pariente B, Zallot C, Dufour G, Fumery M, Baumann C, Amiot A et al..  2019.  Dose de-escalation to adalimumab 40 mg every three weeks in patients with inflammatory bowel disease-A multicenter, retrospective, observational study. DIGESTIVE AND LIVER DISEASE. 51:236-241.
E
Wendling D, Guillot X, Prati C, Miceli-Richard C, Molto A, Lories R, Dougados M.  2020.  Effect of Gut Involvement in Patients with High Probability of Early Spondyloarthritis: Data from the DESIR Cohort. JOURNAL OF RHEUMATOLOGY. 47:349-353.
Wendling D, Prati C, Chouk M, Verhoeven F.  2020.  Effects of anti-IL-23 and anti-IL-17: The hidden side of spondyloarthritis polymorphism? JOINT BONE SPINE. 87:5-7.
Hachem NEl, Abadie C, Longy M, Colas C, Fert-Ferrer S, Leroux D, Grandval P, Prieur F, Collonge-Rame MA, Faivre L et al..  2019.  Endoscopic Phenotype of Monoallelic Carriers of MUTYH Gene Mutations in the Family of Polyposis Patients: A Prospective Study. DISEASES OF THE COLON & RECTUM. 62:470-475.
Tarris G, de Rougemont A, Charkaoui M, Michiels C, Martin L, Belliot G.  2021.  Enteric Viruses and Inflammatory Bowel Disease. VIRUSES-BASEL. 13:104.
F
Lescut D, Bouteloup C, Danel N, Dauchet L, de Luca A, Delarue J, Hasselmann M, Jesus P, Fayemendy P, Pham S et al..  2019.  French epidemiological data regarding home enteral nutrition. NUTRITION CLINIQUE ET METABOLISME. 33:283-289.
G
Dignass A, Akbar A, Baumgart DC, Bommelaer G, Bouguen G, Cadiot G, Gillessen A, Grimaud J-C, Hart A, Hoque S et al..  2018.  Granulocyte/monocyte adsorptive apheresis for the treatment of therapy-refractory chronic active ulcerative colitis. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY. 53:442-448.
H
Jhundoo HD, Siefen T, Liang A, Schmidt C, Lokhnauth J, Moulari B, Beduneau A, Pellequer Y, Larsen CCasper, Lamprecht A.  2021.  Hyaluronic Acid Increases Anti-Inflammatory Efficacy of Rectal 5-Amino Salicylic Acid Administration in a Murine Colitis Model. BIOMOLECULES & THERAPEUTICS. 29:536-544.
I
Rasmussen C, Abitbol V, Karoui KEl, Bourrier A, Paule R, Vuitton L, Maurier F, Laharie D, Fumery M, Agard C et al..  Submitted.  IgA vasculitis in patients with inflammatory bowel disease: new insights into the role of TNF-alpha blockers. RHEUMATOLOGY.
Fournier A, Mondillon L, Luminet O, Canini F, Mathieu N, Gauchez ASophie, Dantzer C, Bonaz B, Pellissier S.  2020.  Interoceptive Abilities in Inflammatory Bowel Diseases and Irritable Bowel Syndrome. FRONTIERS IN PSYCHIATRY. 11:229.
P
Sondag M, Verhoeven F, Guillot X, Prati C, Briot C, Vuitton L, Koch S, Wendling D.  2018.  ``Paradoxical'' arthralgia occurring under anti-TNF alpha treatment for inflammatory bowel disease. JOINT BONE SPINE. 85:119-120.
Nachury M, Bouhnik Y, Serrero M, Filippi J, Roblin X, Kirchgesner J, Bouguen G, Franchimont D, Savoye G, Buisson A et al..  2021.  Patients & rsquo; real-world experience with inflammatory bowel disease: A cross-sectional survey in tertiary care centres from the GETAID group *. DIGESTIVE AND LIVER DISEASE. 53:434-441.
R
Hedjoudje A, Cheurfa C, Briquez C, Zhang A, Koch S, Vuitton L.  2017.  rs2476601 polymorphism in PTPN22 is associated with Crohn's disease but not with ulcerative colitis: a meta-analysis of 16,838 cases and 13,356 controls. ANNALS OF GASTROENTEROLOGY. 30:197-208.
S
Youshia J, Lamprecht A.  2016.  Size-dependent nanoparticulate drug delivery in inflammatory bowel diseases. EXPERT OPINION ON DRUG DELIVERY. 13:281-294.
T
Harb Z, Deckert V, Bressenot AMarchal, Christov C, Gueant-Rodriguez R-M, Raso J, Alberto JMarc, de Barros J-PPais, Umoret R, Peyrin-Biroulet L et al..  2020.  The deficit in folate and vitamin B12 triggers liver macrovesicular steatosis and inflammation in rats with dextran sodium sulfate-induced colitis. JOURNAL OF NUTRITIONAL BIOCHEMISTRY. 84:108415.
V
Caron B, Peyrin-Biroulet L, Pariente B, Bouhnik Y, Seksik P, Bouguen G, Caillo L, Laharie D, Carbonnel F, Altwegg R et al..  2019.  Vedolizumab Therapy is Ineffective for Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A GETAID Multicentre Cohort Study. JOURNAL OF CROHNS & COLITIS. 13:1239-1247.